Stop Guessing.
Know What The Science
Actually Says.

Taking a drug called evolocumab can lower the chance of having a first major heart problem by 25% in people at high risk who’ve never had a heart attack or stroke before.

A weekly diabetes shot called exenatide doesn’t lower the chance of ending up in the hospital for heart failure for the first time in people with type 2 diabetes — it’s basically neutral, even though it might help if someone already has heart issues.

For people with diabetes or clogged arteries who haven’t had a heart attack or stroke yet, taking a drug called evolocumab every two weeks can lower their chance of having a first heart attack, stroke, or heart-related death by about 25% over nearly 5 years.

For people at high risk for heart problems because of diabetes or clogged arteries, taking a drug called evolocumab every two weeks can lower their chances of having a heart attack, stroke, or needing heart surgery by about 1 in 5 over nearly 5 years, compared to those who don’t take it.

Taking a weekly diabetes shot called exenatide doesn’t stop the first heart failure hospital stay, but it does cut down on how often people end up back in the hospital for heart problems by about 18%.

Taking a drug called evolocumab every two weeks is just as safe as taking a fake pill (placebo) for people with certain heart risks — there’s no real difference in side effects after nearly 5 years.